Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Jul;68(1):119–121. doi: 10.1038/bjc.1993.297

Biodistribution and tumour localisation of 131I SWA11 recognising the cluster w4 antigen in patients with small cell lung cancer.

J A Ledermann 1, N J Marston 1, R A Stahel 1, R Waibel 1, J R Buscombe 1, P J Ell 1
PMCID: PMC1968318  PMID: 8391302

Abstract

The biodistribution of radiolabelled SWA11, a mouse monoclonal antibody recognising the cluster w4 group antigen associated with small cell lung cancer (SCLC) was studied in patients with SCLC. Five patients were injected intravenously with approximately 5 mCi of 131I conjugated to 1 mg of SWA11. The half-life of the radiolabel in blood was short but there was a prolonged second phase of clearance with a half-life of about 40 h. Tumour was detected by gamma camera imaging two patients. However, most of the whole body radioactivity was located in the bone marrow. At least 35% of the radioactivity in blood 18 h after injection was bound to circulating granulocytes and this probably accounted for the unusual biodistribution of the radiolabel in man. This study shows that the biodistribution of radiolabelled SWA11 in man differs from human tumour xenograft models and that the antibody in unsuitable for targeting therapy to SCLC in man.

Full text

PDF
119

Images in this article

120Figure 2
on p.120

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Feld R., Evans W. K., Coy P., Hodson I., MacDonald A. S., Osoba D., Payne D., Shelley W., Pater J. L. Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung. J Clin Oncol. 1987 Sep;5(9):1401–1409. doi: 10.1200/JCO.1987.5.9.1401. [DOI] [PubMed] [Google Scholar]
  2. Jackson D., Waibel R., Weber E., Bell J., Stahel R. A. CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. Cancer Res. 1992 Oct 1;52(19):5264–5270. [PubMed] [Google Scholar]
  3. Lenhard R. E., Jr, Order S. E., Spunberg J. J., Asbell S. O., Leibel S. A. Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease. J Clin Oncol. 1985 Oct;3(10):1296–1300. doi: 10.1200/JCO.1985.3.10.1296. [DOI] [PubMed] [Google Scholar]
  4. Order S. E., Stillwagon G. B., Klein J. L., Leichner P. K., Siegelman S. S., Fishman E. K., Ettinger D. S., Haulk T., Kopher K., Finney K. Iodine 131 antiferritin, a new treatment modality in hepatoma: a Radiation Therapy Oncology Group study. J Clin Oncol. 1985 Dec;3(12):1573–1582. doi: 10.1200/JCO.1985.3.12.1573. [DOI] [PubMed] [Google Scholar]
  5. Pedley R. B., Boden J., Keep P. A., Harwood P. J., Green A. J., Rogers G. T. Relationship between tumour size and uptake of radiolabelled anti-CEA in a colon tumour xenograft. Eur J Nucl Med. 1987;13(4):197–202. doi: 10.1007/BF00256491. [DOI] [PubMed] [Google Scholar]
  6. Press O. W., Eary J. F., Badger C. C., Martin P. J., Appelbaum F. R., Levy R., Miller R., Brown S., Nelp W. B., Krohn K. A. Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody. J Clin Oncol. 1989 Aug;7(8):1027–1038. doi: 10.1200/JCO.1989.7.8.1027. [DOI] [PubMed] [Google Scholar]
  7. Smith A., Waibel R., Stahel R. A. Selective immunotherapy of small cell cancer xenografts using 131I-labelled SWA11 antibody. Br J Cancer. 1991 Aug;64(2):263–266. doi: 10.1038/bjc.1991.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Smith A., Waibel R., Westera G., Martin A., Zimmerman A. T., Stahel R. A. Immunolocalisation and imaging of small cell cancer xenografts by the IgG2a monoclonal antibody SWA11. Br J Cancer. 1989 Feb;59(2):174–178. doi: 10.1038/bjc.1989.36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Souhami R. L., Beverley P. C., Bobrow L. G., Ledermann J. A. Antigens of lung cancer: results of the second international workshop on lung cancer antigens. J Natl Cancer Inst. 1991 May 1;83(9):609–612. doi: 10.1093/jnci/83.9.609. [DOI] [PubMed] [Google Scholar]
  10. Souhami R. L., Law K. Longevity in small cell lung cancer. A report to the Lung Cancer Subcommittee of the United Kingdom Coordinating Committee for Cancer Research. Br J Cancer. 1990 Apr;61(4):584–589. doi: 10.1038/bjc.1990.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Wawrzynczak E. J., Derbyshire E. J., Henry R. V., Parnell G. D., Smith A., Waibel R., Stahel R. A. Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer. Br J Cancer Suppl. 1991 Jun;14:71–73. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES